Press Release / Media Release


To,
Dy. General Manager,
Department of Corporate Services,
BSE Ltd.,
P. J. Towers, Dalal Street,
Fort, Mumbai - 400 001.

Ref: Scrip Code: 532296



Dear Sirs,

Sub: Glenmark initiates Phase IIb dose range finding study for novel molecule GRC 27864

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.

Request you to kindly take the same on record.

Thanking you,

Yours faithfully,
For Glenmark Pharmaceuticals Limited


Harish Kuber
Company Secretary & Compliance Officer

Pdf Link: Press Release / Media Release

Source : BSE - www.bseindia.com

Published on January 15, 2018
TOPICS

Related

This article is closed for comments.
Please Email the Editor